Spero Therapeutics (SPRO) Stock Chart & Stock Price History → FW: 234x Gain (From Weiss Ratings) (Ad) Free SPRO Stock Alerts $1.63 +0.02 (+1.24%) (As of 05/3/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Spero Therapeutics Stock Price Performance5 Day Performance+13.19%1 Month Performance-3.55%3 Month Performance+12.03%6 Month Performance+36.97%Year-To-Date Performance+10.88%1 Year Performance-13.30% Receive SPRO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Spero Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsFW: 234x GainThis coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.Click here. SPRO Stock Chart for Saturday, May, 4, 2024 SPRO Chart by TradingView Spero Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/03/2024$1.61$1.63+1.24%$1.65$1.6291,963 shs$87.84 million05/02/2024$1.55$1.61+4.21%$1.67$1.53301,805 shs$86.76 million05/01/2024$1.42$1.55+8.80%$1.57$1.43281,996 shs$83.26 million04/30/2024$1.44$1.42-1.39%$1.48$1.4295,313 shs$76.52 million04/29/2024$1.46$1.44-1.37%$1.50$1.42170,558 shs$77.61 million04/26/2024$1.43$1.46+2.10%$1.51$1.42164,757 shs$78.68 million Get the Latest News and Ratings for SPRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Spero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/25/2024$1.42$1.43+0.70%$1.46$1.39167,906 shs$77.06 million04/24/2024$1.44$1.42-1.05%$1.45$1.41110,042 shs$76.52 million04/23/2024$1.41$1.44+2.14%$1.48$1.40123,862 shs$77.33 million04/22/2024$1.40$1.41+0.36%$1.45$1.37295,169 shs$75.72 million04/19/2024$1.47$1.40-4.76%$1.54$1.40378,240 shs$75.45 million04/18/2024$1.50$1.47-2.00%$1.55$1.46240,214 shs$79.19 million04/17/2024$1.47$1.50+2.04%$1.53$1.47208,975 shs$80.81 million04/16/2024$1.53$1.47-3.92%$1.61$1.47162,265 shs$79.19 million04/15/2024$1.64$1.53-6.71%$1.68$1.53271,871 shs$82.42 million04/12/2024$1.71$1.64-4.09%$1.71$1.62338,094 shs$88.35 million04/11/2024$1.70$1.71+0.59%$1.75$1.6796,259 shs$92.12 million04/10/2024$1.69$1.70+0.59%$1.74$1.67111,984 shs$91.58 million04/09/2024$1.68$1.69+0.60%$1.73$1.6886,736 shs$91.04 million04/08/2024$1.65$1.68+1.82%$1.74$1.66259,830 shs$90.50 million04/05/2024$1.69$1.65-2.37%$1.75$1.65175,812 shs$88.89 million04/04/2024$1.79$1.69-5.59%$1.80$1.68275,940 shs$91.04 million04/03/2024$1.80$1.79-0.56%$1.79$1.72260,717 shs$96.43 million04/02/2024$1.79$1.80+0.56%$1.81$1.72432,030 shs$96.97 million04/01/2024$1.72$1.79+4.07%$1.81$1.70374,303 shs$96.43 million03/29/2024$1.72$1.72$1.76$1.72154,085 shs$92.66 million03/28/2024$1.75$1.72-1.71%$1.76$1.72154,066 shs$92.66 million03/27/2024$1.73$1.75+1.16%$1.75$1.71371,561 shs$94.27 million03/26/2024$1.69$1.73+2.37%$1.74$1.68217,232 shs$93.19 million03/25/2024$1.75$1.69-3.43%$1.74$1.67259,998 shs$91.04 million03/22/2024$1.73$1.75+1.16%$1.75$1.71167,826 shs$94.27 million03/21/2024$1.76$1.73-1.70%$1.78$1.71255,023 shs$93.19 million03/20/2024$1.78$1.76-1.12%$1.78$1.72221,246 shs$94.81 million03/19/2024$1.73$1.78+2.89%$1.80$1.66305,253 shs$95.89 million03/18/2024$1.79$1.73-3.35%$1.78$1.65903,375 shs$93.20 million03/15/2024$1.74$1.79+2.87%$1.84$1.681.07 million shs$94.87 million03/14/2024$1.66$1.74+4.82%$1.89$1.704.27 million shs$92.22 million03/13/2024$1.66$1.66$1.71$1.65469,135 shs$87.98 million03/12/2024$1.74$1.66-4.60%$1.75$1.65283,110 shs$87.98 million03/11/2024$1.66$1.74+4.82%$1.75$1.66303,369 shs$92.22 millionGold Mania (Ad)Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here.03/08/2024$1.73$1.66-4.05%$1.77$1.66204,363 shs$87.98 million03/07/2024$1.72$1.73+0.58%$1.75$1.65267,272 shs$91.69 million03/06/2024$1.67$1.72+2.99%$1.73$1.65130,004 shs$91.16 million03/05/2024$1.67$1.67$1.70$1.6560,557 shs$88.51 million03/04/2024$1.69$1.67-1.18%$1.73$1.65182,098 shs$88.51 million03/01/2024$1.65$1.69+2.42%$1.73$1.63164,693 shs$89.57 million02/29/2024$1.66$1.65-0.60%$1.68$1.63138,186 shs$87.45 million02/28/2024$1.64$1.66+1.22%$1.71$1.63350,324 shs$87.98 million02/27/2024$1.50$1.64+9.33%$1.68$1.52963,966 shs$86.92 million02/26/2024$1.51$1.50-0.66%$1.57$1.49145,870 shs$79.50 million02/23/2024$1.47$1.51+2.72%$1.52$1.4584,774 shs$80.03 million02/22/2024$1.51$1.47-2.65%$1.57$1.46229,837 shs$77.91 million02/21/2024$1.53$1.51-1.31%$1.53$1.5068,497 shs$80.03 million02/20/2024$1.53$1.53$1.57$1.49227,655 shs$81.09 million02/19/2024$1.53$1.53$1.55$1.51151,900 shs$81.09 million02/16/2024$1.52$1.53+0.66%$1.55$1.51149,278 shs$81.09 million02/15/2024$1.48$1.52+3.05%$1.55$1.49128,296 shs$80.56 million02/14/2024$1.46$1.48+1.03%$1.51$1.4553,149 shs$78.18 million02/13/2024$1.50$1.46-2.67%$1.55$1.45110,152 shs$77.38 million02/12/2024$1.37$1.50+9.49%$1.55$1.37548,603 shs$79.50 million02/09/2024$1.35$1.37+1.48%$1.40$1.3564,749 shs$72.61 million02/08/2024$1.45$1.35-6.90%$1.46$1.33265,278 shs$71.55 million02/07/2024$1.48$1.45-2.03%$1.49$1.4360,895 shs$76.85 million02/06/2024$1.44$1.48+2.78%$1.50$1.4572,700 shs$78.44 million02/05/2024$1.46$1.44-1.03%$1.50$1.42169,508 shs$76.32 million Related Companies: Connect Biopharma Stock Price Chart Tempest Therapeutics Stock Price Chart Hookipa Pharma Stock Price Chart Marinus Pharmaceuticals Stock Price Chart YS Biopharma Stock Price Chart Corvus Pharmaceuticals Stock Price Chart Oncolytics Biotech Stock Price Chart InflaRx Stock Price Chart Aileron Therapeutics Stock Price Chart vTv Therapeutics Stock Price Chart Receive SPRO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Spero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SPRO) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe only AI company you should be looking atBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spero Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.